Impaired insight in schizophrenia: impact on patient-reported and physician-reported outcome measures in a randomized controlled trial

BACKGROUND: Impaired insight poses a challenge in the treatment of patients with schizophrenia because of its potential to jeopardize therapeutic engagement and medication adherence. This study explored how insight impairment, graded from none to extreme, is related to patient-reported mental health...

Descripción completa

Detalles Bibliográficos
Autores principales: Lysaker, Paul H., Weiden, Peter J., Sun, Xiaowu, O’Sullivan, Amy K., McEvoy, Joseph P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420291/
https://www.ncbi.nlm.nih.gov/pubmed/36031632
http://dx.doi.org/10.1186/s12888-022-04190-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420291/
https://www.ncbi.nlm.nih.gov/pubmed/36031632
http://dx.doi.org/10.1186/s12888-022-04190-w

Ejemplares similares